FDA’s drug manufacturing oversight a potentially deadly problem

The latest setback for Johnson & Johnson’s COVID-19 vaccine was the U.S. Food and Drug Administration’s order on June 11, 2021, to discard 60 million doses that failed to meet quality and safety guidelines. A Baltimore manufacturing facility run by Emergent BioSolutions had been producing COVID-19 vaccines for both J&J and AstraZeneca and inadvertently mixed up ingredients from the two companies.

Long article

https://www.krqe.com/health/coronavirus/fdas-drug-manufacturing-oversight-a-potentially-deadly-problem/